A long-running experiment in serial mouse cloning has produced a sharp scientific reversal. A 2013 peer-reviewed report suggested somatic cell nuclear transfer (SCNT), the technique used to create Dolly the sheep, could be repeated for many generations in mice without obvious, clone-specific abnormalities. New findings reported in 2026, as described by Reuters, challenge that earlier picture, reporting that repeated cloning over the long term was associated with harmful genetic mutations that accumulated across generations. The results could prompt a reassessment of cloning’s viability for conservation, agriculture, and regenerative medicine.
Early Optimism From 25 Generations of Clones
The story begins with what appeared to be a triumph. A peer-reviewed study published in Cell Stem Cell described serial SCNT recloning across 25 generations in mice, yielding more than 500 viable offspring from a single original donor. The researchers reported no observed accumulation of clone-specific abnormalities and no declining efficiency across generations. A separate summary of the work put the total at 581 clones with normal lifespans, reinforcing the idea that cloning could theoretically continue indefinitely.
Supporting that optimism, microarray expression profiling of brain and liver tissue from neonatal controls, standard somatic cell clones, and 20th-generation recloned mice was deposited in the Gene Expression Omnibus as dataset GSE43476. In the 2013 report, the authors did not describe a clear pattern of worsening expression abnormalities across successive rounds of cloning in the samples they analyzed. More broadly, the results were widely read at the time as evidence that serial SCNT might not inevitably compound detectable problems over many generations.
Warning Signs in Parallel Research
Even as the 25-generation results circulated, other lines of research hinted at trouble. As early as 2002, work at the Whitehead Institute at MIT documented abnormal gene expression patterns in the placentas and livers of cloned mice. Those array-based expression abnormalities suggested that cloning introduced at least some measurable genomic disruption, even if the animals appeared outwardly healthy.
A separate study on induced pluripotent stem cells, published in Nature Communications, examined mutation patterns under sequential reprogramming and explicitly discussed serial SCNT recloning as a comparison point. That research found that repeated reprogramming and cell culture were associated with copy number alterations and single nucleotide variant accumulation, along with viability changes across generations. The findings applied to iPSCs rather than whole-animal cloning, but they raised a direct question: if reprogramming in a dish causes mutations to pile up, why would the same process inside an egg cell be immune?
Researchers at The Scripps Research Institute added another piece to the puzzle. Their work used cloning-derived approaches to expand single neurons into stem cell lines and produce mice carrying neuronal mutations in all cells. That study illustrated a critical and often overlooked mechanism: cloning can capture and propagate pre-existing somatic mutations from the donor cell. In other words, mutations do not have to arise during cloning itself. The process can amplify damage that already existed at low levels in the source tissue.
Two Decades Later, the Picture Darkens
The tension between early optimism and accumulating warning signs came to a head with a 2026 report that described grave genetic mutations arising from repeated cloning in mice. According to Reuters, the lead researcher expressed deep disappointment: “We had believed that we could create an infinite number of clones. That is why these results are so disappointing.”
This finding appears to differ from the earlier Cell Stem Cell report, which reported no observed accumulation of clone-specific abnormalities and no declining efficiency across the generations it examined. It also sits uneasily alongside summaries that described cloned mice with normal lifespans. One possible explanation is that different endpoints were measured: outward health and lifespan over limited observation windows may not capture slow, generation-by-generation mutation buildup that becomes detectable only after many rounds and long follow-up. Reuters described the newer work as spanning roughly two decades.
How Mutations Build Across Cloned Generations
Researchers have proposed more than one way mutations could accumulate across cloned generations. One possibility is de novo mutation associated with the cloning process and early embryonic development, including errors during DNA replication. Another, highlighted by the Scripps neuron-cloning work, is amplification of pre-existing somatic mutations from the donor cell. Each round of cloning selects a single cell as the template for an entire organism, meaning any mutations in that cell can become fixed in the next generation and potentially compound with additional changes in subsequent rounds.
Research on mouse spermatogonial stem cells provides a useful benchmark. That study measured mutation accumulation under repeated clonal propagation in a mouse stem-cell system over multi-year culture, using whole-genome sequencing comparisons across timepoints and subclones. While the system involved in vitro propagation rather than whole-animal SCNT, it demonstrated that clonal expansion itself, independent of nuclear transfer, can drive measurable genomic change over time. The principle applies broadly: any system that copies a genome repeatedly without the genetic mixing of sexual reproduction risks ratcheting up mutations.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
